HELLP Syndrome Grading Using the Mississippi Classification
The Mississippi classification system grades HELLP syndrome into three classes based on the platelet nadir: Class 1 (platelets ≤50,000/mm³), Class 2 (platelets >50,000 to ≤100,000/mm³), and Class 3 (platelets >100,000 to ≤150,000/mm³), with Class 1 representing the most severe form associated with significantly higher maternal morbidity and mortality. 1, 2
Classification System Details
The Mississippi Triple-Class system stratifies HELLP syndrome severity based on the lowest platelet count documented:
- Class 1: Platelets ≤50,000/mm³ (most severe)
- Class 2: Platelets >50,000 to ≤100,000/mm³ (moderate)
- Class 3: Platelets >100,000 to ≤150,000/mm³ (mild)
All classes require the presence of hemolysis (elevated LDH >600 U/L) and elevated liver enzymes (AST ≥70 U/L) for complete HELLP syndrome diagnosis 3. When only 2 of the 3 diagnostic parameters are present, this is termed "partial" or "incomplete" HELLP syndrome 1.
Clinical Significance of Classification
The Mississippi classification has critical prognostic value. Class 1 HELLP syndrome carries dramatically worse outcomes compared to all other classes:
- Composite Major Maternal Morbidity (CMMM):
- Class 1: 44%
- Class 2: 13%
- Class 3: 24%
- Partial HELLP: 20%
- Severe preeclampsia without HELLP: 18% 1
The difference in CMMM between Class 1 and all other groups is statistically significant (p<0.001) 4, 1. Up to 85% of maternal morbidity and mortality occurs in Class 1 disease 2.
Why This Classification Matters
Failing to separately evaluate Class 1 patients obscures the true risk profile. When Class 1 and Class 2 patients are combined in studies, the overall morbidity rate drops to 22.1%, which becomes statistically indistinguishable from other groups—thereby masking the significantly elevated risk in Class 1 patients 4. This has important implications for:
- Treatment intensity: Class 1 and Class 2 patients should receive the Mississippi Protocol (corticosteroids, magnesium sulfate, blood pressure control) 5, 6
- Monitoring requirements: Class 1 requires more aggressive surveillance and earlier delivery consideration
- Counseling: Maternal mortality is 4.7% overall but concentrated in Class 1 disease 2
- Research interpretation: Studies must report Class 1 outcomes separately to accurately assess treatment effectiveness 4
Disease Progression
The classification is dynamic—patients can progress between classes. When the Mississippi Protocol is initiated early in Class 2 or Class 3 disease, only 24% progress to Class 1, and only 18.2% of Class 1 patients develop new major maternal morbidity 5. This demonstrates that the classification not only predicts risk but also helps guide intervention timing to prevent progression to the most dangerous stage.
Common Pitfall
Do not combine HELLP classes when reporting outcomes or making treatment decisions. The profound difference in morbidity between Class 1 (44%) and Class 2 (13%) means these groups require different management intensity and have vastly different prognoses 1. Always specify which class is being discussed when evaluating HELLP syndrome cases.